MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 194 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $524,394 | -34.1% | 15,790 | -37.4% | 0.00% | 0.0% |
| Q3 2022 | $796,000 | -49.7% | 25,230 | -51.5% | 0.00% | -50.0% |
| Q2 2022 | $1,583,000 | +16.6% | 52,065 | -0.5% | 0.00% | 0.0% |
| Q1 2022 | $1,358,000 | +37.6% | 52,321 | +8.1% | 0.00% | +100.0% |
| Q4 2021 | $987,000 | -18.9% | 48,380 | -23.5% | 0.00% | -50.0% |
| Q3 2021 | $1,217,000 | -26.2% | 63,230 | -15.0% | 0.00% | 0.0% |
| Q2 2021 | $1,650,000 | +54.1% | 74,396 | +82.3% | 0.00% | 0.0% |
| Q1 2021 | $1,071,000 | +79.1% | 40,802 | +27.6% | 0.00% | +100.0% |
| Q4 2020 | $598,000 | +25.6% | 31,980 | +14.0% | 0.00% | 0.0% |
| Q3 2020 | $476,000 | -2.7% | 28,060 | +1.3% | 0.00% | -50.0% |
| Q4 2016 | $489,000 | +61.9% | 27,690 | +76.9% | 0.00% | +100.0% |
| Q3 2016 | $302,000 | +2.7% | 15,651 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $294,000 | -2.6% | 15,075 | +3.0% | 0.00% | -50.0% |
| Q1 2016 | $302,000 | – | 14,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |